Ghanem O, Pita A, Nazzal M, Johnson S, Diwan T, Obeid N
Surg Endosc. 2024; 38(8):4138-4151.
PMID: 38951240
PMC: 11289013.
DOI: 10.1007/s00464-024-10930-8.
Ramendra R, Fernandez-Castillo J, Huszti E, Ghany R, Aversa M, Havlin J
ERJ Open Res. 2023; 9(5).
PMID: 37817870
PMC: 10561084.
DOI: 10.1183/23120541.00222-2023.
Hashemi-Bajgani S, Samareh-Fekri M, Paghaleh A, Yazdani R, Zarandi M, Shafahi A
Ethiop J Health Sci. 2022; 32(4):715-722.
PMID: 35950065
PMC: 9341028.
DOI: 10.4314/ejhs.v32i4.7.
Varma S, Yun J, Kim J, Podolanczuk A, Patel N, Bernstein E
J Scleroderma Relat Disord. 2022; 7(2):128-134.
PMID: 35585957
PMC: 9109501.
DOI: 10.1177/23971983221083882.
Guerreiro Cardoso P, Minamoto H, Bibas B, Pego-Fernandes P
Transl Cancer Res. 2022; 9(3):2123-2135.
PMID: 35117568
PMC: 8799195.
DOI: 10.21037/tcr.2020.03.24.
Bacterial infections in lung transplantation.
Mccort M, Mackenzie E, Pursell K, Pitrak D
J Thorac Dis. 2022; 13(11):6654-6672.
PMID: 34992843
PMC: 8662486.
DOI: 10.21037/jtd-2021-12.
Bile acids inhibit cholinergic constriction in proximal and peripheral airways from humans and rodents.
Urso A, DOvidio F, Xu D, Emala Sr C, Bunnett N, Perez-Zoghbi J
Am J Physiol Lung Cell Mol Physiol. 2019; 318(2):L264-L275.
PMID: 31800261
PMC: 7474253.
DOI: 10.1152/ajplung.00242.2019.
Role of gastroesophageal reflux disease in lung transplantation.
Hathorn K, Chan W, Lo W
World J Transplant. 2017; 7(2):103-116.
PMID: 28507913
PMC: 5409910.
DOI: 10.5500/wjt.v7.i2.103.
Effects of bile acids on human airway epithelial cells: implications for aerodigestive diseases.
Aldhahrani A, Verdon B, Ward C, Pearson J
ERJ Open Res. 2017; 3(1).
PMID: 28344983
PMC: 5360888.
DOI: 10.1183/23120541.00107-2016.
Esophageal Dysmotility, Gastro-esophageal Reflux Disease, and Lung Transplantation: What Is the Evidence?.
Wood R
Curr Gastroenterol Rep. 2015; 17(12):48.
PMID: 26454656
DOI: 10.1007/s11894-015-0474-9.
Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation.
Neujahr D, Uppal K, Force S, Fernandez F, Lawrence C, Pickens A
Am J Transplant. 2014; 14(4):841-8.
PMID: 24666830
PMC: 5505513.
DOI: 10.1111/ajt.12631.
Relevance of GERD in lung transplant patients.
Mertens V, Dupont L, Sifrim D
Curr Gastroenterol Rep. 2010; 12(3):160-6.
PMID: 20425473
DOI: 10.1007/s11894-010-0106-3.
A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.
Davis C, Gagermeier J, Dilling D, Alex C, Lowery E, Kovacs E
Clin Transplant. 2010; 24(3):E54-61.
PMID: 20331688
PMC: 3066066.
DOI: 10.1111/j.1399-0012.2010.01243.x.
Symptomatic gastroesophageal reflux disease after lung transplantation.
Molina E, Short S, Monteiro G, Gaughan J, Macha M
Gen Thorac Cardiovasc Surg. 2009; 57(12):647-53.
PMID: 20013099
DOI: 10.1007/s11748-009-0486-1.
Pulmonary manifestations of gastroesophageal reflux disease.
Gaude G
Ann Thorac Med. 2009; 4(3):115-23.
PMID: 19641641
PMC: 2714564.
DOI: 10.4103/1817-1737.53347.
Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients.
Mertens V, Blondeau K, Pauwels A, Farre R, Vanaudenaerde B, Vos R
Dig Dis Sci. 2009; 54(5):972-9.
PMID: 19241165
DOI: 10.1007/s10620-009-0725-4.
Antireflux surgery for patients with end-stage lung disease before and after lung transplantation.
Gasper W, Sweet M, Hoopes C, Leard L, Kleinhenz M, Hays S
Surg Endosc. 2007; 22(2):495-500.
PMID: 17704875
DOI: 10.1007/s00464-007-9494-3.
